New Zealand - Export of Heparin for Therapeutic Use

Since 2014, New Zealand Export of Heparin for Therapeutic Use decreased by 3.7% year on year. In 2019, the country was ranked number 25 comparing other countries in Export of Heparin for Therapeutic Use at $5,796,837.1. New Zealand is overtaken by Denmark, which was ranked number 24 with $5,814,161.34 and is followed by Austria at $5,291,062.18. China topped the ranking with $1,237,456,257.9 in 2019, a decrease of 3% compared to 2018. United States, France and Singapore respectively ranked number 2, 3 and 4 in this ranking. Montenegro recorded the best 5 years average growth at +490.8% per year, while Greenland recorded the worst performance at -78.9% per year.

Loading...

Date US Dollars
2019 5,796,837.10
2018 6,504,064.00
2017 3,592,539.75
2016 4,366,201.00
2015 3,625,524.00
Download all data from 1989 to 2019

How does New Zealand rank in Export of Heparin for Therapeutic Use?

# 109 Countries US Dollars Last YoY 5‑years CAGR
1 #1
China
1,237,456,257.90 2019 -3.0 % +6.7 % View data
2 #2
United States
528,184,315.05 2019 +3.8 % -15.3 % View data
24 #24
Denmark
5,814,161.34 2019 +12.9 % -19.9 % View data
25 #25
New Zealand
5,796,837.10 2019 -10.9 % -3.7 % View data
26 #26
Austria
5,291,062.18 2019 -18.5 % +18.1 % View data
Compare all 109 countries

Go Top